Illness cognitions in head and neck squamous cell carcinoma: Predicting quality of life outcome by Scharloo, M. (Margreet) et al.
ORIGINAL ARTICLE
Illness cognitions in head and neck squamous cell
carcinoma: predicting quality of life outcome
Margreet Scharloo & Robert J. Baatenburg de Jong &
Ton P. M. Langeveld & Els van Velzen-Verkaik &
Margreet M. Doorn-op den Akker & Adrian A. Kaptein
Received: 3 February 2009 /Accepted: 13 August 2009 /Published online: 29 August 2009
# The Author(s) 2009. This article is published with open access at Springerlink.com
Abstract
Goals of work This paper presents an observational study
of the longitudinal effects of cancer treatment on quality of
life (QoL) in patients treated for head and neck squamous
cell carcinoma (HNSCC), and evaluated the contribution of
patients' baseline illness cognitions to the prediction of QoL
2 years after diagnosis.
Patients and methods One hundred seventy-seven patients
eligible for primary treatment for HNSCC completed the
Illness Perception Questionnaire-Revised at baseline and
the European Organization for Research and Treatment of
Cancer Core Quality of Life Questionnaire-30 at baseline,
at 1-year and 2-year follow-ups.
Main results Compared to baseline, patients reported better
emotional functioning at both follow-ups (p<0.001), worse
social functioning at 12 months (p<0.05), and better global
health status at 24 months (p<0.05). Patients' own implicit
common sense beliefs about their illness added small but
significant amounts of variance to the prediction of QoL
after 2 years. Less belief in own behavior causing the
illness predicted better functioning and better global health.
Strong illness identity beliefs predicted worse functioning
and worse global health. Negative perceptions about the
duration of the illness (chronic timeline beliefs) and more
negative perceived consequences also predicted worse
QoL.
Conclusions Our results on the negative perceptions about
the duration of the illness, perceived consequences, and
high symptom awareness predicting worse QoL illustrate
the detrimental effects of uncertainty and negative expect-
ations about the future course of the illness. The identifi-
cation of these cognitive factors provides possible targets
for counseling strategies to assist patients in long-term
adjustment to HNSCC.
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Introduction
Over more than 40 years, a variety of individual and group-
based psychosocial interventions has been developed
specifically for people with cancer. Although the findings
of several meta-analyses and research reviews have
suggested the overall usefulness of psychosocial interven-
tions for enhancing coping and improving quality of life
(QoL) in adult cancer patients [1–4], other researchers have
concluded their reviews with a more pessimistic assessment
that the evidence on efficacy is inconclusive at best [5, 6].
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One of the suggestions to shed light on these mixed
conclusions regarding effectiveness of psychosocial inter-
ventions is to study potential moderators of intervention
efficacy, such as cancer type, interventionist, and type of
intervention [7, 8]. With regard to type of intervention,
results from meta-analyses studying the efficacy of various
components of interventions show that those with a greater
number of components related to social cognitive theory
(self-efficacy beliefs, information processing, and expect-
ations regarding outcome and self-regulation, i.e., the
process of planning, monitoring, and changing one's
behaviors and cognitions) predicted better short- and/or
long-term QoL outcomes for cancer patients than do
interventions lacking those components [3, 9].
Another suggested approach is to evaluate whether
psychological process-level variables (e.g., self-esteem,
perceived control) contribute to the outcome through
mediating and/or moderating effects [10]. With respect to
cognitive factors, studies identifying potential mechanisms
by which interventions in cancer care may exert their
effects on QoL are few. Only one intervention study tested
whether a cognitive behavioral intervention modified
cognitive factors (perceived stress management skills), and
whether improvement in QoL was mediated by greater
perceived skills [11]. Other studies suggested cognitive
factors such as: fear of recurrence [12, 13], belief in
curability [14], recovery expectations [15–17], cognitive
appraisal of cancer threat [18], and patients' perceptions of
their illness and treatment [19–21].
Although there has been minimal research into effective
psychosocial intervention programs specifically for head
and neck cancer patients, there is evidence to indicate that
psychosocial interventions focusing on monitoring and
altering cancer-relevant cognitions, emotions, and behav-
iors also have a positive effect in enhancing QoL in these
patients [22–26].
Our study aims to identify specific cognitions that are
(un)helpful in longer term adjustment to head and neck
squamous cell carcinoma (HNSCC) as a useful step toward
designing interventions for HNSCC patients. The self-
regulation model (SRM) of Leventhal et al. [27] was
adopted as a general conceptual framework for identifying
the subjective cognitions (ideas, views, and beliefs) and
emotional responses generated by the illness that contribute
to adjustment after cancer treatment. According to the
SRM, patients will form commonsense representations
when presented with information that constitutes a threat
to health, integrating internal and external stimulus infor-
mation with their own preexisting illness theory. The SRM
identifies two simultaneous processes—i.e., cognitive and
affective—that make independent and potentially interac-
tive contributions to health and illness behavior [28]. The
model posits that the cognitive representations are concep-
tualized by patients along five core dimensions: beliefs
about the illness' identity (beliefs about the disease label
and the symptoms associated with the illness), possible
cause (beliefs about how one gets the disease), timeline of
the illness (beliefs about the likely duration of illness and its
expected course), controllability (beliefs about which
strategies can cure/control the illness), and consequences
(the perceived severity and beliefs about the physical,
social, economic, and emotional effects of the illness).
Preliminary support for the use of this model for explaining
changes in health behavior and QoL in cancer patients
comes from studies in patients with breast cancer [29–32]
and patients with head and neck cancer [33].
Our specific objectives were to extend our prior research
in this area, in which we demonstrated that illness
cognitions were significantly related to pretreatment QoL
[21], by analyzing longitudinal data, determining relation-
ships between baseline illness cognitions, and QoL out-
come 2 years after diagnosis.
Patients and methods
Study population
This is a prospective observational study, in which the study
population consisted of all incident patients with head and
neck squamous cell carcinoma who were diagnosed at the
Department of Otolaryngology and Head and Neck Surgery
at the Leiden University Medical Center, The Netherlands,
between March 2002 and August 2005. Patients were
followed-up until death or 2 years after diagnosis.
Patients were included if they were eligible for primary
treatment for squamous cell carcinomas in the pharynx, larynx,
oral cavity, nose, sinuses, esophagus, or salivary glands.
Patients who were mentally retarded, demented, or unable to
fill in the questionnaires for other reasons were excluded.
One hundred seventy-seven patients meeting study
criteria were enrolled. The characteristics of the study
sample are depicted in Table 1.
Procedure
Patients were invited to participate by a research nurse on
the day of diagnostic testing. All patients were informed on
the purpose of the study. The study was exempted from
institutional review board approval because the question-
naires were administered as part of standard clinical care to
assist treatment planning. For baseline assessment consent-
ing, patients were handed a questionnaire packet, and they
completed the questionnaires while waiting for the next
diagnostic procedure, with the research nurse available to
respond to questions. For follow-up measurements, patients
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Table 1 Demographic, treatment, and tumor-related characteristics of the study population
At baseline (n=177) Dead (n=53) Missing (n=29) Final sample (n=95)
Age (year)
Mean (SD) 59.5 (11.3) 62.1 (11.8) 54.1 (10.1) 59.6 (10.8)
Range 28–84 40–84 28–70 36–84
Gender (n)
Male 131 41 18 72
Female 46 12 11 23
Treatment (n)
None 4 2 – 2
Irradiation only 72 23 14 35
Surgery and irradiation 42 11 10 20
Surgery only 39 8 4 27
Chemotherapy only or combination with chemotherapy 20 9 1 11
Tumor (sub)sites (n)
Pharynx
Nasopharynx 10 4 1 5
Oropharynx 46 15 8 23
Hypopharynx 18 9 2 7
Larynx 42 10 7 25
Oral cavity 38 8 9 21
Other 23 7 2 14
Tumor stage (n)
T0 4 1 – 3
T1 32 3 2 27
T2 51 13 15 23
T3 37 12 5 20
T4 44 18 6 20
Tx 9 6 1 2
Nodal stage (n)
N0 90 20 15 55
N1 21 3 6 12
N2 49 21 5 23
N3 8 4 1 3
Nx 9 5 2 2
Distant metastasis (n)
M0 160 42 28 90
M1 6 5 – 1
Mx 11 6 1 4
AJCC/UICC tumor stage (n)
I 27 2 1 24
II 29 8 9 12
III 34 6 8 20
IV 80 33 10 37
Unknown 7 4 1 2
Prior malignancy (n)
No 162 45 28 89
Yes 15 8 1 6
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received a questionnaire packet by mail. Upon completion,
the packet was returned to the research nurse by mail, or
handed in by the patient at their follow-up visit.
Measurement
The Illness Perception Questionnaire-Revised (IPQ-R) [34]
was used to measure patients' cognitive and emotional
representations of their illness. The first part of the
questionnaire measures the illness identity dimension with
a list of 14 commonly occurring symptoms: pain, sore
throat, nausea, breathlessness, weight loss, fatigue, stiff
joints, sore eyes, wheezinass, headaches, upset stomach,
sleep difficulties, dizziness, and loss of strength. Patients
are asked to rate whether or not they have experienced each
symptom since their illness, and if they believe the
symptom to be specifically related to their illness (yes or
no). The summed yes-rated items on the second question
form the illness identity scale, with higher scores indicating
a stronger belief that the experienced symptoms are part of
the patient's illness.
The second part of the IPQ-R consists of 38 statements
using five-point Likert scale (range “strongly agree” to
“strongly disagree”) and provides separate scores for the
consequences, timeline (divided into the subscales: cyclical
timeline and acute/chronic timeline), control (divided into
the subscales: personal control and treatment control),
illness coherence, and emotional representations scales.
High scores indicate stronger beliefs in: serious consequen-
ces of the disease, a chronic long-term disease, illness and/
or symptoms as cyclical in nature, the patients' own ability
to control symptoms, and the effectiveness of treatment in
controlling the illness. Higher scores on the illness
coherence scale indicate a higher degree to which patients
feel they have a coherent model of the illness, and higher
scores on the emotional representations scale indicate a
stronger emotional response to illness.
The third part, questions about causal attributions, uses
the same five-point scale and consists of 18 items. Only the
causal attributions that were endorsed by more than 20% of
this patient group (“chance”, “smoking”, “own behavior”,
“alcohol”, and “stress”) were included in further analyses.
Since “smoking”, “alcohol” and “own behavior” were
highly correlated (Pearson correlation>0.50, p<0.000),
these items were summed together to form the “own
behavior” subscale. Higher scores indicate stronger beliefs
in own behavior, chance, or stress causing the illness.
Means (± standard deviation (SD)) and reliability coeffi-
cients (Cronbach's α) for the IPQ-R scales are shown in
Table 2. Reliability coefficients ranged from 0.70 to 0.92,
indicating satisfactory internal consistency.
The European Organization for Research and Treatment
of Cancer Core Quality of Life Questionnaire 30 (EORTC
QLQ-30; version 3) [35] was used to measure quality of
life. It consists of 30 items, yielding nine summary scales:
physical functioning, role functioning, emotional function-
ing, social functioning, cognitive functioning, global health
status, fatigue, pain, and nausea, and six single items. With
the exception of the global health status items, patients
respond on four-point Likert scale (difficulties during the
last week, range “not at all” to “very much”). Global
quality of life is rated on a seven-point visual analog scale
(health and quality of life during the last week, range “very
poor” to “excellent”). Higher scores for functional scales
and global health status represent a high level of function-
ing/quality of life, whereas high scores for symptoms
represent high levels of impairment. The scales and single
items of the QLQ-C30 were scored and transformed to
scales of 0 to100 according to the EORTC Quality of Life
Study Group scoring guidelines.
Scales IPQ-R Mean (SD) Cronbach's α
Illness identity 2.61 (2.62) 0.79
Consequences 19.11 (4.40) 0.76
Timeline
Cyclical 9.68 (2.96) 0.70
Acute/chronic 17.12 (4.45) 0.86
Control
Personal 18.33 (3.51) 0.74
Treatment 17.53 (3.15) 0.78
Illness coherence 15.78 (4.05) 0.75
Emotional representations 18.93 (6.43) 0.92
Causal attributions
Behavioral (alcohol, smoking, my own behavior) 8.28 (3.20) 0.80
Chance 3.28 (1.22) –
Stress 2.35 (1.19) –
Table 2 Mean scores (SD) and
internal reliability scores
(Cronbach's α) of the Illness
Perception Questionnaire-
Revised (IPQ-R) scales
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Statistical analysis
All data were analyzed using the Statistical Package for the
Social Sciences (SPSS 14.0 forWindows). The significance of
differences between patients who completed measurements
and those who died or dropped out was tested using chi-square
statistics and Student's t test. Descriptive means, standard
deviations, and Cronbach's alpha for the IPQ-R subscales
were calculated at baseline. A one-way repeated measures
analysis of variance was conducted to explore changes in
QLQ-C30 functioning and global health status scales at
diagnosis, at 12 months and 24 months follow-ups. Multiple
regressions were used to examine if baseline illness
perceptions explained variance on QLQ-C30 functioning
and global health status scales 2 years after diagnosis. For
each QoL scale, multiple regression equations were comput-
ed. Age and American Joint Committee on Cancer (AJCC)/
International Union Against Cancer (UICC) tumor stages
were force-entered on the first step, and baseline measure-
ment of the outcome variable was force-entered on the
second step to correct for the possible influence of these
factors on QoL at 24 months. On the third step, a selection of
the IPQ-R subscales were entered stepwise into the
regressions to examine which illness perceptions explain
variance independently from and on top of age, tumor stage,
and baseline QoL. To limit the number of variables entered
into the regressions and avoid multicollinearity, only the
IPQ-R cognitive and emotional representations scales that
correlated significantly with QoL at 2 years were entered.
Results
Patients
Patients were followed prospectively over 2 years. From the
initial patient sample, 53 patients died before the end of the
study (30%), 29 patients withdrew (16%), and 95 patients
completed measurements at 24 months. Patients who died
within study period and patients who withdrew did not
differ from participants who completed on baseline QoL or
illness cognitions, except for chronic timeline beliefs—
patients who died had higher chronic belief at baseline
(F(2,149)=6.9, p<0.001). With respect to demographic,
treatment, and tumor-related characteristics (see Table 1),
patients who withdrew differed from patients who com-
pleted on AJCC/UICC tumor stage (χ2=10.3, df=3; p<
0.05). Patients who withdrew were significantly less
frequently diagnosed in stage I (4% vs 26%) and more
frequently in stage II (32% vs. 13%). Patients who died also
differed from patients who completed on AJCC/UICC
tumor stage (χ2=9.8, df=3; p<0.05), with the majority of
patients who died being diagnosed in stage IV (62.5%).
Quality of life over time
Scores on the QLQ-C30 functioning and global health status
scales were compared across time for patients who completed
measurements at 24 months (see Fig. 1). Significant effects
for time were found for emotional functioning (Wilks'
lambda=0.73; F(2,65)=11.84, p<0.001), social functioning
(Wilks' lambda=0.90; F(2,65)=3.52, p<0.05), and global
health status (Wilks' lambda=0.90; F(2,62)=3.44, p<0.05),
with significantly better emotional functioning at 12 and
24 months as compared to baseline (p<0.001), social
functioning being worse at 12 months (p<0.05), but not
significantly different from baseline at 24 months (p=0.06),
and better global health status scores at 24 months as
compared to baseline (p<0.05).
Predicting quality of life
As evident in Table 3, tests of the significance of the
variables in the equations revealed that age and AJCC/
UICC tumor stages (step 1) did not significantly contribute
to the variance in any of the QLQ-C30 scales at 24 months
postdiagnosis. With the exception of role functioning,
baseline QLQ-C30 functioning (step 2) explained most of
the variance in functioning (47%, 42%, 26%, and 64% in
physical, emotional, social, and cognitive functioning,
respectively) and in global health (31%). Better baseline
functioning predicted better functioning at 24 months.
When we examine the additional variance explained by
baseline illness cognitions, results show that consequences
beliefs (4%) and behavioral attributions (3%) significantly
* p=≤0.05; *** p=≤0.001
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Fig. 1 Differences between QLQ-C30 functioning scales and global
health scale scores at diagnosis and at follow-up (12 months and
24 months); * p=≤0.05; *** p=≤0.001
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and uniquely added to the variance explained in QLQ-C30
physical functioning. Lower perceived consequences scores
and less belief in own behavior causing the illness were
associated with better physical functioning. Together with
identity perceptions, behavioral attributions and perceived
consequences beliefs also contributed significantly to the
variance in QLQ-C30 role functioning (15%, 9%, and 4%,
respectively) and global health status (14%, 7%, and 3%,
respectively) with fewer perceived symptoms, less belief in
own behavior causing the illness, and lower consequences
scores being associated with better role functioning and
higher global health status ratings. Behavioral attributions
also contributed significantly to the variance in QLQ-C30
social functioning (5%), with less belief in own behavior
causing the illness being associated with better social
functioning. With regard to cognitive functioning, chronic
timeline perceptions added a small but significant 2% to the
prediction. Belief that the illness will be permanent was
associated with worse cognitive functioning.
Discussion
This paper presents an observational study of the longitu-
dinal effects of cancer treatment on QoL in HNSCC
patients, exploring the contribution of baseline illness
cognitions to the prediction of QoL 2 years after diagnosis.
The general findings in the present study suggest that,
Step and variablea Beta Summarized R2 (%) R2 change (%) F of change (p value)
Physical functioning
1. Age 3% 3% NS
Illness stage
2. Physical functioning T1 0.60 50% 47% ***
3. Consequences −0.19 54% 4% *
Behavioral attributions −0.18 56% 3% *
Role functioning
1. Age 1% 1% NS
Illness stage
2. Role functioning T1 9% 8% NS
3. Illness identity −0.44 24% 15% ***
Behavioral attributions −0.26 32% 9% **
Consequences −0.22 36% 4% *
Emotional functioning
1. Age 1% 1% NS
Illness stage
2. Emotional functioning T1 0.65 42% 42% ***
Social functioning
1. Age 2% 2% NS
Illness stage
2. Social functioning T1 0.29 27% 26% ***
3. Illness identity −0.50 50% 23% ***
Behavioral attributions −0.22 55% 5% *
Cognitive functioning
1. Age 1% 1% NS
Illness stage
2. Cognitive functioning T1 0.78 64% 64% ***
3. Timeline chronic −0.15 67% 2% *
Global health
1. Age 4% 4% NS
Illness stage
2. Global health T1 0.23 35% 31% ***
3. Illness identity −0.39 48% 14% ***
Behavioral attributions −0.25 55% 7% **
Consequences −0.18 58% 3% *
Table 3 Regression analyses:
percentages of variance on the
QLQ-C30 functioning scales
and global health scale
explained by age, illness stage,
functioning at baseline, and ill-
ness perceptions
a Illness perceptions dimensions
entered for the prediction of the
QLQ-C30 functioning scales
included: physical functioning:
identity, consequences, and
behavioral attributions; role
functioning: identity, consequen-
ces, and behavioral attributions;
emotional functioning: identity,
consequences, emotional repre-
sentations, and stress attributions;
cognitive functioning: identity,
timeline chronic, timeline cycli-
cal, consequences, emotional
representations, and stress attri-
butions; social functioning:
identity, timeline cyclical,
consequences, illness coherence,
emotional representations,
behavioral attributions, stress
attributions; global health:
identity, timeline chronic,
consequences, emotional
representations, behavioral
attributions, and stress
attributions
NS nonsignificant
*p<0.05; **p<0.01, ***p<
0.001
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although pretreatment QoL is by far the strongest predictor
of QoL at 2-year follow-up, illness cognitions add small but
significant amounts of variance to the prediction, with
behavioral attributions, perceived consequences, and illness
identity beliefs as the most consistent predictors.
Longitudinal results from prospective studies in head
and neck cancer patients show a general trend that QoL
deteriorates during and directly after treatment and restores
to pretreatment levels after 12 months, despite functional
disabilities [36]. Studies with longer follow-up periods
report no clinical significant improvements in QoL after
1 year, with physical functioning and role functioning
deteriorating over time and emotional functioning and
global health improving [37–39]. Findings in our sample
on quality of life over time closely parallel these results.
Less belief in own behavior causing the illness was
predictive of better physical, role, and social functioning
and better global health in our sample. These results
strengthen our previous cross-sectional findings [21] and
confirm the negative effects of self-blame in cancer found
by others, who reported that stronger self-blame attributions
were related to more psychological distress and poorer QoL
in patients with breast cancer [40–43]. Also, self-blame was
found to be associated with potentially health-damaging
behavior following treatment in patients with head and neck
cancer [44]. Christensen et al. found that patients who
attributed the cause of their cancer to their past substance
use exhibited a higher likelihood of continued smoking, but
only if they also reported a low degree of perceived control
over their future cancer-related health. Other studies found
that blaming one's past behaviors for cancer does not
(automatically) enhance perceptions of control over future
recovery/recurrence [40, 42, 43] and conclude that health-
care professionals should offer support to discourage the
use of self-blame.
Strong baseline illness identity beliefs predicted worse
social and role functioning and worse global health after
2 years. High symptom awareness predicting distress was
also found in a study by Millar et al. [29]. It is suggested
that persistent vigilance to somatic signs is associated with
fear of recurrence (FoR) and that even common, noncancer-
like symptoms (such as tiredness and headaches) will
become part of patients' illness models, thus playing a
major role in evoking FoR [13, 45]. FoR can arise already
before treatment [46, 47], is one of the most frequently
reported concerns for many cancer patients [48], and is an
important stressor in the lives of both patients and
significant others [49–51]. Our results on the negative
perceptions about the duration of the illness (chronic
timeline beliefs) and more negative perceived consequences
at baseline predicting worse QoL also illustrate the
detrimental effects of uncertainty and negative expectations
about the future course of the illness. The results are
consistent with previous research in showing that the way
patients conceptualize their cancer appears to be more
influential in determining levels of posttreatment distress
than objective indicators of the likelihood of recurrence (e.g.,
stage of disease) or performance status (Karnofsky status)
[15, 30]. Studies examining QoL in long-term cancer
survivors have reported that uncertainty in illness extends
the impact of cancer well beyond the treatment phase and
has a direct negative influence on patients' QoL [12, 45, 50,
52–54]. According to the self-regulation model, patients'
illness cognitions help determine their illness-related
behaviors and attempts to control distress. We speculate
that those who have more negative expectations about the
future course of the illness may be less motivated to engage
in adaptive strategies to remain well and psychologically
healthy, both during and after treatment. The stronger
associations between negative illness cognitions and social
and role functioning in our study might indicate that these
patients are less successful in organizing social support.
One of the limitations of the current study is that the
sample is inherently biased toward patients who survived.
Patients who remained in the study were recruited into the
study with significantly earlier stage tumors, and our data
are, therefore, biased toward patients with relatively less
physical consequences of treatment. Also, our longitudinal
design does not take into account the concerns raised by
Llewellyn et al. [33] that baseline factors such as illness
cognitions are likely to change over the course of the
illness. Within the SRM, it is posited that illness cognitions,
health-related responses, and evaluation of health outcome
are recursive stages in illness trajectories, thus suggesting
that studying the process of change in illness cognitions
might be more appropriate than studying pretreatment
beliefs as predictors of longitudinal outcomes. In our study,
illness cognitions were measured in the initial stages of
treatment (even before patients received their definitive
diagnosis), and since, it is likely that over the course of a
(very burdensome) treatment patients' beliefs will fluctuate,
this might explain why baseline illness cognitions only
added small amounts of variance to the prediction of
follow-up QoL. From our results, however, it can also be
tentatively concluded that by changing pretreatment cogni-
tive factors, long-term functional outcome after treatment
for HNSCC can be improved.
Understanding the experience of illness from the
perspective of the patient provides clinically relevant
information to guide intervention and treatment. In partic-
ular, when assisting patients to adjust to HNSCC, from our
results, it seems that supportive care need to target patients'
cognitions about own behavior causing the illness, illness
identity beliefs, chronic timeline beliefs, and perceived
consequences. Intervention trials addressing uncertainty
and FoR underline the importance of influencing negative
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cognitions in reducing uncertainty and strengthening QoL
outcome after cancer [13, 55, 56]. One intervention was
especially designed to assist patients with uncertainty
during watchful waiting in prostate cancer. This study
documents benefits of cognitive reframing and refocusing
attention to satisfying and rewarding areas of life [55].The
very recently developed intervention by Humphris and
Ozakinci [13] seems promising and concentrates on
symptom identification and recurrence fear management,
discussion of illness beliefs, and moderation of excessive
checking behavior in patients with head and neck cancer.
Results from intervention studies with a focus on self-
regulation in other illnesses show that changing illness
perceptions is possible and can result in improved func-
tional outcome [57–59].
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